Stratec (ETR:SBS) Shares Down 1.4% – What’s Next?

Stratec SE (ETR:SBSGet Free Report)’s stock price dropped 1.4% during mid-day trading on Friday . The stock traded as low as €21.70 and last traded at €21.70. Approximately 16,852 shares were traded during mid-day trading, an increase of 170% from the average daily volume of 6,253 shares. The stock had previously closed at €22.00.

Stratec Price Performance

The business has a fifty day moving average of €24.30 and a 200 day moving average of €26.07. The firm has a market cap of $260.70 million, a P/E ratio of 26.04, a PEG ratio of 10.43 and a beta of 0.16. The company has a quick ratio of 1.65, a current ratio of 2.52 and a debt-to-equity ratio of 66.97.

Stratec Company Profile

(Get Free Report)

Stratec SE, together with its subsidiaries, designs and manufactures automation and instrumentation solutions in the fields of in-vitro diagnostics and life sciences in Germany, European Union, and internationally. It designs and manufactures automated analyzer systems for clinical diagnostics and biotechnology customers; and offers complex consumables for diagnostics and medical applications.

See Also

Receive News & Ratings for Stratec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stratec and related companies with MarketBeat.com's FREE daily email newsletter.